RBC Capital maintains Mirum Pharmaceuticals Outperform
RBC Capital kept Mirum Pharmaceuticals at Outperform and raised its price target to $155 from $135.
Story updates
03:06:19 PM UTC
SquawkNews
Mirum Pharmaceuticals Price Target Raised to $155.00/Share From $135.00 by RBC Capital